Focused Investors LLC Decreases Holdings in UnitedHealth Group Incorporated $UNH

Focused Investors LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 489,700 shares of the healthcare conglomerate’s stock after selling 12,400 shares during the quarter. UnitedHealth Group makes up approximately 4.3% of Focused Investors LLC’s portfolio, making the stock its 12th biggest position. Focused Investors LLC’s holdings in UnitedHealth Group were worth $132,508,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in UNH. Swisher Financial Concepts Inc. raised its position in UnitedHealth Group by 5.5% in the 1st quarter. Swisher Financial Concepts Inc. now owns 960 shares of the healthcare conglomerate’s stock worth $260,000 after purchasing an additional 50 shares during the period. Triad Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 11.3% in the first quarter. Triad Wealth Partners LLC now owns 4,826 shares of the healthcare conglomerate’s stock worth $1,306,000 after buying an additional 489 shares during the period. Park National Corp OH lifted its stake in shares of UnitedHealth Group by 32.4% in the 1st quarter. Park National Corp OH now owns 1,727 shares of the healthcare conglomerate’s stock valued at $467,000 after acquiring an additional 423 shares during the last quarter. Diversified Trust Co grew its position in UnitedHealth Group by 11.2% during the 1st quarter. Diversified Trust Co now owns 52,833 shares of the healthcare conglomerate’s stock worth $14,296,000 after acquiring an additional 5,333 shares during the last quarter. Finally, Future Financial Wealth Managment LLC lifted its position in UnitedHealth Group by 3.6% in the first quarter. Future Financial Wealth Managment LLC now owns 2,136 shares of the healthcare conglomerate’s stock valued at $578,000 after purchasing an additional 75 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.0%

Shares of NYSE UNH opened at $400.86 on Monday. The firm has a fifty day simple moving average of $373.69 and a two-hundred day simple moving average of $329.60. The firm has a market capitalization of $364.04 billion, a PE ratio of 30.28, a price-to-earnings-growth ratio of 1.61 and a beta of 0.64. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $415.98.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the previous year, the company earned $7.20 earnings per share. UnitedHealth Group’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is 70.09%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on UNH shares. UBS Group raised their target price on shares of UnitedHealth Group from $410.00 to $460.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Weiss Ratings raised shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Jefferies Financial Group boosted their price objective on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Bank of America upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their target price for the stock from $420.00 to $450.00 in a report on Thursday, June 4th. Finally, Oppenheimer boosted their price target on UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $409.75.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.